This document brings together a diverse collection of maps from different continents and countries, depicting small area estimates of vital development indicators, including health indicators such as infant mortality rate, at unprecedented levels of spatial detail. The atlas of 21 full-page poverty maps reveals possible causal patterns and provides practical examples of how the data and tools have been used, and may be used, in applied decisions and poverty interventions.
Where There Are No Pharmacists is about managing medicines. It explains how to order them, store them, prepare them, dispense them and use them safely and effectively. This book provides advice on all these aspects for people working with medicines as well as information to help communities benefit from the use of medicines. It provides guidance for anyone who is doing the work of a pharmacist; anyone who sells, dispenses, prepares, manages, or explains to others how to use medicines. It is especially intended for use in developing countries.
Recent snapshot surveys of research institutions in the African and Asian regions have revealed some significant gaps in the contracting and contract management capacity of low- and middle-income country (LMIC) institutions in these regions. Many institutions had not previously considered research contracting to be a legal issue and reported having no specialist legal expertise, with the result that contractual terms and conditions were often poorly understood. Without adequate legal capacity, contract negotiations can lead to agreements which disadvantage the LMIC partner. This guidance booklet is aimed at optimising research institution building through better contracts and contracting in research partnerships. It highlights the key issues for consideration when entering into formalised research partnerships, and provides tools and resources for negotiating fairer research contracts. Better contract negotiation expertise in LMIC institutions will help improve the distribution of benefits of collaborative research, such as overhead costs, data ownership, institutional capacity in research management, technology transfer, and intellectual property rights.
The Commission on Macroeconomics and Health (CMH) has created an electronic newsletter to provide up-to-date information about national efforts to increase investment in health and improve the effectiveness of health expenditure. The MacroHealth Newsletter will feature Macroeconomics and Health Support Secretariat news, new findings on health investment and economic growth, country CMH launches and progress in implementing national work in macroeconomics and health.
In a single electronic platform, the WHO’s Communicable Disease Global Atlas brings together for analysis and comparison standardised data and statistics for infectious diseases at country, regional and global levels. The analysis and interpretation of data are further supported through information on demography, socioeconomic conditions and environmental factors. In so doing, the Atlas specifically acknowledges the broad range of determinants that influence patterns of infectious disease transmission.
The WHO Global InfoBase has, for the first time, assembled in one place, country level risk factor data stratified by age and sex, with complete source and survey information. The current version of the InfoBase contains over 45,000 data points from more than 2,000 sources. The NCD InfoBase contains data for 170 out of 192 WHO Member States. A unique feature is that each record can be linked back to all its survey information, including the primary source. This is important when the collection of such data involves so many different protocols and definitions.
The World Health Organization (WHO) has launched the Global Network of Age-friendly Cities as part of a broader response to the rapid ageing of populations. WHO notes that populations in almost every corner of the world are growing older. The greatest changes are occurring in less-developed countries. By 2050, it is estimated that 80% of the expected 2 billion people aged 60 years or over will live in low- or middle-income countries. The Network aims to help cities create urban environments that allow older people to remain active and healthy participants in society. While the response to population ageing has often focussed on the implications for governments of increasing demand for pensions and health care, WHO tries to place more emphasis on the positive contributions older people make to society. It underlines the importance for older people of access to public transport, outdoor spaces and buildings, as well as the need for appropriate housing, community support and health services. But it also highlights the need to foster the connections that allow older people to be active participants in society, to overcome ageism and to provide greater opportunities for civic participation and employment. Cities that are interested in joining the Network, should contact Dr John Beard at the email address given.
The new WHO Macroeconomics and Health website was launched in May 2003. The website will provide detailed information on WHO macro-economics and health work, the latest action in countries, news and links with related sites, and links to the CMH Report and its Working Group Reports. Published documents and reports can be downloaded from the site. To ensure that the website becomes a forum for sharing ideas, information and news, readers are encouraged to submit their views and work on macroeconomic and health issues.
This is the first Model Formulary for Children released by the World Health Organization (WHO), which provides information on how to use over 240 essential medicines for treating illness and disease in children from 0 to 12 years of age. A number of individual countries have developed their own formularies over the years, but until now there was no single comprehensive guide to using medicines in children for all countries. The Model Formulary is the first resource for medical practitioners worldwide that provides standardised information on the recommended use, dosage, adverse effects and contraindications of medicines for use in children. The new Formulary is based on the best global evidence available as to which medicines should be used to treat specific conditions, how they should be administered and in what dose. The Formulary also identifies a number of areas where more research is needed to provide better treatment for children, such as child appropriate antibiotics to treat pneumonia and specific medicines for neonatal care.
PHM follows closely the work of WHO, both through the World Health Assembly and the Executive Board. A team of PHM volunteers attends WHO bodies’ meetings – following the debate, talking with delegates and making statements to the EB. The PHM’s commentaries covers most of the agenda items of the WHO bodies’ meetings and includes a note on the key issues in focus at the meeting, a brief background and critical commentary. Reports on key issues are also prepared. PHM is part of a wider network of organizations committed to democratizing global health governance and working through the WHO-Watch project. Information from PHM on the proceedings of the May 2019 World Health Assembly can be found at the website provided.